Category Archives: Fertility Tourism

Risks flagged in India’s fertility tourism

by Neeta Lal

The revolutionary in vitro fertilization (IVF) technique that has given the world about five million new people in the 34 years since the birth the world’s first test tube baby, Louise Brown, continues to court controversy in India.

Earlier this month, Bombay High Court chastised the Maharashtra state police for being lackadaisical in investigating the circumstances that led to the death of 17-year-old Sushma Pandey shortly after she donated her ovum at a suburban Mumbai fertility clinic two years ago.

The process of egg donation – or assisted reproduction – involves the donor providing eggs, ova or oocytes for fertilization in a laboratory after being injected with stimulating hormones. Apart from the blood group and physical fitness, height, weight, educational qualifications and professions are all recorded. According to the Indian Council of Medical Research (ICMR) guidelines, it is mandatory to maintain a gap of at least three months between donations.
Apparently in Sushma’s case, almost all the ICMR guidelines were blatantly violated. While an egg donor has to be between 21 and 35 years of age, Sushma was barely 17 she donated her eggs without her parents’ knowledge. And while she made donations thrice in 18 months an obligatory gap of three months between egg donations was ignored.

What rankles most, say activists, is that the girl was not remunerated by the fertility clinic, the salient reason why poor women agree to such highly invasive medical procedures. In other words, the clinic simply harvested Sushma’s eggs without compensating her and then went on to commercially profit from them. Reportedly, the teen was promised $ 550 for each donated ovum.

“If Sushma had donated the ovum thrice, she should have been paid 75,000 rupees [US$1,600]. But we have not received a paisa [cent] of the money she earned,” the girl’s mother told an Indian newspaper.

In the second such tragedy, Premila Vaghela, 30, who had rented out her womb to a US couple, died this May in the eighth month of a surrogate pregnancy reportedly due to negligence at a clinic in Ahmedabad in western Gujarat. Though Premila managed to deliver her surrogate child, her own two young children are now motherless.

Both episodes highlight the grey area in which “assisted reproductive clinics” (ART) continue operate in the country’s US$500 million fertility tourism industry. They also underscore the deficiency of laws to check malpractices.

Acknowledging this, ICMR said in a report last year that “Most of the new technologies aimed at taking care of infertility involve handling of the gamete – spermatozoa or the ooctye – outside the body … These technologies not only require expertise, but also open up many avenues for unethical practices that can affect adversely the recipient of the treatment, medically, socially and legally.”

The report added that “The last 20-odd years have seen an exponential growth of infertility clinics that use techniques. As of today, anyone can open infertility or ART clinic; no permission is required to do so. There has been, consequently, a mushrooming of such clinics around the country. In the public interest therefore, it has become important to regulate the functioning of such clinics to ensure that the services provided are ethical and that the medical, social and legal rights of all those concerned are protected.”

ICMR is setting up a national registry of assisted reproductive technology clinics. Until such a registry becomes operational, experts advocate that the Indian parliament clear a path-breaking ART Bill, 2010, which has been stuck in a legislative log jam. The proposed Bill seeks to put in place several important provisions to protect the rights of surrogates.

The pending legislation clearly states that a woman acting as surrogate mother in India cannot be less than 21 years or over 35 years and that she cannot give more than five live births, including her own children. There are safety nets that the Bill seeks to build for the surrogates – they should not undergo embryo transfer more than three times for the same couple and no ART bank or clinic can send an Indian citizen for surrogacy abroad. Strict confidentiality, according to the proposed bill, also needs to be maintained about the donor’s identity.

Most doctors concede the need for a legal framework for the industry, although some feel it is unfair to tarnish all fertility clinics with the same brush because good ones are indeed a boon to childless couples.

“Surrogacy is one of the well-accepted concepts of assisted reproduction,” said renowned IVF expert Dr Indira Hinduja, who gave the country its first test tube babies in the 80s, told this correspondent earlier. “It benefits patients who can’t conceive or carry a pregnancy to term. Such people can take the help of surrogates to carry their child in the uterus and then hand it over to the genetic parents post delivery.”

Demand from childless couples around the world for Indian surrogate mothers has turned “surrogacy tourism” into a fast-growing business. Driving the demand are India’s advantages are laws that are less restrictive than elsewhere, a lack of ART regulation, the easy availability of surrogate mothers and medical procedures that cost a fraction of what they do in the West.

According to the private Indian Society for Assisted Reproduction (ISAR), there are more than 600 IVF clinics in the country providing an estimated 60,000 assisted reproductive treatments a year. While the government legalized commercial surrogacy in 2002, the only code governing surrogacy transactions in the country is a 126-page document issued by ICMR in 2005, which lays down the National Guidelines for Accreditation, Supervision and Regulation of ART Clinics in India.

The guidelines are legally non-binding, as they have not yet been ratified by the Indian Parliament. Besides, the ICMR rules are ambiguous about vital issues like the rights of the surrogate, the minimum age of the surrogate, details about the contracts, informed consent and adoption requirements.

What also needs to be brought under the law’s ambit, say experts, is clarity on the issue of legal parentage. “Most childless couples spend whopping sums of money on airfare and surrogacy contracts only to be told at the last minute that they can’t take their baby out of the country till cumbersome paperwork is completed,” says Dr Anita Palwal, a Delhi-based gynecologist-obstetrician.

Palwal recounts the case of Manji Yamada, the daughter of a Japanese couple who was born in Anand through a surrogacy agreement in 2010. Manji’s parents were divorced midway through the surrogacy agreement and her Japan-based mother then refused to accompany the father to pick up the newborn from India. Indian laws wouldn’t allow the baby to leave the country unless accompanied by her mother. Finally, Manji’s paternal grandmother had to step in to take her back to Japan.

Another disconcerting area, say activists and bio-ethicists, are the rights of the infertile couple. “For instance,” said Vrinda Vassan, an activist volunteer for Bachpan, a pan-India children’s rights organization, “there must be a mechanism to assure that the donor’s unused harvested eggs or embryos are not sold by the fertility clinics to other couples for profit. The misuse of a surrogate child for purposes of terrorism, prostitution or unethical genetic engineering research also needs looking into.”

Increasingly, whimsies are also creeping into the business. A few fertility clinics in central Bihar’s capital Patna, for instance, are getting cases of local childless couples who nag the hospital staff about the caste of the sperm or egg donor before they sign on the dotted line. “This makes a mockery of the entire IVF process. The focus should always be on the “quality” of sperm and not the trivia,” said Dr Palwal.

Experts agree that while the proposed ART Bill won’t be a panacea for all the ills, it will at least sensitize the stakeholders about their rights while acting as a deterrent for unscrupulous merchants of the trade.

Neeta Lal is a widely published writer/commentator who contributes to many reputed national and international print and Internet publications.

source: http://www.atimes.com / Asia Times Online / Home> South Asia / By Neeta Lal / August 01st, 2012

Eggs on demand in lawless market

Advancing technology and growing medical tourism have helped in vitrio fertilsation thrive in India, but with little regulation. Egg donors are chosen and paid according to their profile, with touts and agencies arranging them for hospitals and recipients. And the donor is often at risk, a fact highlighted by the death of Sushma Pandey, 17, in Mumbai.

With the Assisted Reproductive Technology (Regulation) Bill of 2010 hanging fire, the only attempt at regulation is a set of guidelines, revised several times, by the Indian Council of Medical Research. Clauses in the guidelines appear to contradict each other on the donor’s ideal age, but Sushma would have been under the lower limit in any case.

In the absence of regulation and of “egg banks” — sperm banks do exist — IVF centres and hospitals often perform as banks, authorities say. “Once the law is made, IVF centres and hospitals cannot perform the role of banks,” says Dr R S Sharma, ICMR deputy director general (reproductive medicine), who has been involved in the drafting of the ART Bill. He cites malpractices such as the role of middlemen and the exploitation of donors.

With no checks on clinics yet, many IVF centres are thriving only on cases of egg donation and surrogacy. Dr Tanya B Rohatgi, senior consultant (reproductive medicine) at Max Superspecialty Hospital in Delhi, says, “Egg donation and surrogacy should be practised as the last resort. But in our country we have so many IVF clinics that perform only these two procedures.”

There is no database of ART clinics either, and hence no centralised records of complications developed by the donor.

Donor’s health

The guidelines are silent on the dosage of inducing agents, with the result that donors in higher demand are often made to produce more eggs than what is safe for them. A healthy woman produces one egg every month. For donors, doctors give gonadotrophins, injections that stimulate the ovaries into producing more eggs. After these mature, the donor is put under anaesthesia and the eggs are retrieved via needles and guided by an ultrasound image.

“The guidelines do not specify any dose of gonadotrophins. While the dose should be individual-specific, ethically one should only attempt at extracting five to 18 viable eggs after stimulation,” says Dr Suneeta Mittal, head of AIIMS’s IVF unit. “There are many centres extracting as many as 50 eggs by increasing the dose to dangerous levels.”

High doses can lead to a condition known as ovarian hyper-stimulation. OHS involves hormonal imbalances that can lead to life-threatening conditions. Doctors say the risk is in higher in younger women — who are in higher demand.

If care is not taken during extraction, it can also lead to injuries in the ureter, the fallopian tube, the ovary and the pelvis. A gynaecologist from a Delhi IVF centre says one donor came back after four months with an injured kidney.

“In the West there are dosage specifications. The mild-to-moderate range is considered safe but many clinics in India do not stick to it, because our guidelines do not specify any such thing,” says Dr Abha Majumdar, chief of the IVF centre at Sir Gangaram Hospital.

Many clinics, doctors say, go up to 40-50 eggs so that one donor can serve more than one couple. “If I tell a couple the waiting list in my clinic is two months, and a neighbouring clinic says they can provide a suitable donor within 15 days, will they wait? So we sometimes share eggs taken from a donor in a single cycle — even the ICMR guidelines permit that, provided we are able to extract at least 14 eggs in the cycle,” says a gynaecologist at an IVF centre in Delhi.

Demand & supply

A market that banks on anonymity puts a premium on looks. “Age 28, Qualification: B Com, 5’1”, black eye, black hair. Healthy with no illness, blood pressure etc. Did work as Man(a)ger,” reads an advertisement on the Delhi IVF website. Health Ministry officials say they cannot act against any internet advertisement.

“Donors get paid on the basis of their looks and education. It could range from Rs 35,000 to Rs 75,000 but for a really good-looking graduate donor it could go up to Rs 1 lakh,” says Dr Anoop Gupta of Delhi IVF Fertility Research Centre, insisting “we do all the tests and rarely extract eggs for more than two cycles from one donor”. The tests are for HIV and other sexually transmitted diseases, hepatitis B and C, and genetic diseases like thalassaemia.

Though there is an anonymity clause in the guidelines, most recipients prefer to have at least one glimpse of the donor, say those associated with the process. Not too many bother about the donor’s name but the surname sometimes matters for caste reasons, though recipients don’t insist on this as frequently as they do on the caste of a sperm donor.

Most donors are provided to hospitals by agencies, while touts help strike a deal in some cases, with advertisements calling for donors. “They pay you up to Rs 40,000 every time you donate,” the online advertisement for one clinic reads.

With hospitals unwilling to name the agencies they deal with, just how much reaches the donor is unclear. “Agencies charge as much as the donor. It can be in the range of Rs 20,000-25,000,” says IVF specialist Dr Mangla Telang, insisting they ensure the guidelines are followed. And Dr Nalini Mahajan of Mother and Child Hospital says, “The agency we source our eggs from charges a cumulative Rs 70,000 for each donor though we prefer to do the tests ourselves.”

Recipient couples too are uncertain how the payment is broken up. A Delhi-based couple says, “We paid Rs 3 lakh. We don’t know how much the donor or the agency was paid out of this.”

Many agencies have tie-ups with international donors, or offer Indian donors abroad. “NRIs see Indian donors as a cheap option. They have packages where doctors in the home country examine the donor, while the couple are examined in their country,” says Dr Rohatgi. In such “agreements”, the couple only come to the donor’s country for a week, when the medical procedures are carried out.

The laws

The guidelines allow both advertisement for and payment to egg donors. This is unlike the laws for organ donation, which frown on payment. Authorities say the two cannot cannot be compared.

“We have a very high population of infertile couples, so we need as many donors as possible,” says Dr Sharma of ICMR. In gamete (sperm and eggs) donation, part of the payment goes into funding the tests.

There also is ambiguity about the ideal age of a donor. Clause 3.5.8 reads: “Gametes produced by a person under the age of 21 shall not be used. The accepted age… for the donor woman [should be] between 18 and 35 years.” Later article 3.7.4 says the donor’s age should be between 21 and 35.

The ideal gap between consecutive donations is about three cycles. The guidelines limit extractions to six in a lifetime; the Mumbai donor had at least three since age 16.

Supreme Court advocate Rajeev Dhawan, part of the ART Bill drafting committee, says there will be no scope for middlemen once the ART law comes into effect. “The point of the bill is transparency and any centre — like the one in Mumbai — found involved in violations should be shut down.”

The ICMR is in the process of putting together a voluntary national registry of ART clinics and banks. “We have contacted 886 banks so far, of which 226 have shown an interest in registering,” says Dr Sharma.

source: http://www.indianexpress.com / Home> IE> Story / by Abantika Ghosh & Pritha Chatterjee / New Delhi, Monday July 16th, 2012

Govt mouthpiece bats for surrogacy tourism

Ahmedabad:

Branding surrogacy as “reproductive tourism”, the official mouthpiece of the Gujarat government has described the practice as a money-spinner for both the state and the surrogates. This comes even as issues surrounding commercial surrogacy continue to be debated.

“Today in this fast-paced technological world, remote solutions such as surrogacy have now become common realities. Some of us would deridingly call it a womb-on-rent, when a woman bears a child for someone else…,” says an article in the latest issue of The Gujarat.

The quarterly magazine, published by the state Commissionerate of Information, carries a cover story on Swami Vivekananda and has a “special feature” on reproductive tourism.

Written as a first person narrative of a personal visit to a town in south Gujarat, the article, titled Where the storks dare to fly…, states: “It is indeed remarkable that one small city in Gujarat has turned into reality, what might seem to be a distant dream for the rest of India. The state has set a precedent in embracing humanist ideas by facilitating reproductive tourism, which has proved immensely valuable.”

Talking about the surrogates — mostly women from poor socio-economic backgrounds, who get paid between Rs 2.5-Rs 4 lakh for bearing a child mostly for childless NRIs or foreigners — the author writes, “Apart from empowering the surrogates, it is bringing a lot of revenue for the state… furthering its development.”

The article focuses mostly on the surrogacy clinic of Dr Nayana Patel that thrives in Anand. The home of India’s milk revolution is described in the article as “unassuming town which has made an indelible mark on the world map for reproductive tourism”.

“Cynics may argue on the ethics of the process. But can cynics give a child to a childless couple and empower surrogates not only through financial independence, but also through a sense of working for a noble cause?” Dr Patel is quoted as saying in the article.

While the government has been promoting medical tourism for about a decade now, the tourism policy does not carry any mention about surrogacy or its promotion. “We cannot patronise any one discipline,” state Health and Family Welfare Minister Jaynarayan Vyas told The Indian Express when asked about the government’s official stand on surrogacy.

“It is one of the accepted medical fields that has its own accepted nuances and standard practices. There are several IVF clinics in Gujarat that are run by highly trained and capable professional doctors. However, like any other law it has its own hazards,” added the minister who felt that surrogacy in India had “deep roots” and could be traced to “Vedas” and “Puranas”.

However, last week’s incident wherein a 30-year-old surrogate mother died at an Ahmedabad hospital while carrying a kid for a American couple, has added a new dimension to the debate on surrogacy. The woman, Premila Vaghela, was eight-month pregnant and is survived by two children.

While the Vaghela family refused to speak to on the issue, Dr Patel from Anand said, “At present, the contracts signed between the surrogate mother and the couple (whose baby she is carrying) does not talk of any compensation in case of death of the surrogate mother. Those who agree to become surrogates are told well in advance about the complications involved in pregnancy.”

Dr Patel, who has so far overseen birth to 496 surrogate children at her clinic in Anand since 2004, added that though it was “difficult to find insurance companies are who are willing to insure pregnant women”, her clinic had “instances in the past where surrogate mothers were insured for a sum of Rs 2 lakh in case of death”.

source: http://www.ExpressIndia.com / Home> Story / by Avinash Nair / May 21st, 2012

Vancouver Fertility Travel Company Partners with Hawaiian Island IVF Institute

IVF Vacation Center, a Vancouver, British Columbia medical tourism company specializing in arranging overseas fertility treatments, announced today that they are now partnering with the Fertility Institute of Hawaii.

Partnership provides fertility treatment assistance and hope to those in need.

IVF Vacation Center, a Vancouver, British Columbia medical tourism company specializing in arranging overseas fertility treatments, announced today that they are now partnering with the Fertility Institute of Hawaii to provide  IVF in Hawaii.

The Fertility Institute of Hawaii was founded to provide advanced fertility treatment to infertile couples in Hawaii, the Pacific, the Western United States, Canada, Australia and Asia. As the premier IVF clinic in Hawaii and the surrounding area, the Fertility Institute of Hawaii offers all modern fertility services and has some of the best pregnancy rates in the world. Their overall desire is to produce a pregnancy that will result in the birth of a normal and healthy child using methods that optimize the utilization of a client’s emotional, financial and physical resources.

“At the Fertility Institute, we understand the needs and fears of our patients. We also realize that every patient has very different and specific concerns,” said Dr. John L. Frattarelli, Medical, Practice and Laboratory Director for the Fertility Institute. “We strive to always provide personalized care, and treat all patients as individuals in order to optimize each patient’s treatment outcome.

”Frattarelli is a world renowned expert in infertility and In Vitro Fertilization, with over 20 years experience treating infertile couples. Dr. Frattarelli has participated in over 25,000 fertility treatment cycles resulting in over 10,000 babies. This makes Dr. Frattarelli, and the Fertility Institute of Hawaii, one of the most experienced fertility centers, providing state of the art advanced services including in-vitro fertilization, intracytoplasmic sperm injection, intrauterine inseminations, ovulation induction, and fertility preservation using embryo, egg, or sperm cyroperservation.

“Hawaii provides not only a world-class site for fertility treatments but a fantastic destination which just enhances the holistic approach to care.  We know that stress is the enemy of fertility, so what better way than to be treated in paradise?” said Mark Semple, president of IVF Vacation Center. “We are pleased to partner with The Fertility Institute of Hawaii to provide the best quality medical assistance to our clients.”

IVF Vacation Center is a Vancouver-based fertility tourism company.  IVF Vacation Center seeks to facilitate the whole process of finding and coordinating quality fertility treatmentsat reduced cost or in stress-free, value–added destinations – from making initial contacts, to answering fertility-related questions, to scheduling, and final arrangements. They have successfully managed over 900 patients, and their parent company was awarded the “Leadership Excellence in Medical Facilitation” award at the 4th Annual World Medical Tourism and Global Healthcare Congress held in Chicago.

To learn more, visit the IVF Vacation Center, visit them on the web at http://www.ivfvacationcenter.com For additional information regarding the Fertility Institute of Hawaii, visit  http://www.ivfcenterhawaii.com

source: http://www.webwire.com / Home> News by Industry / Wednesday, March 28th, 2012

PlacidWay Develops New Relationship With Leading IVF and Fertility Center in Colombia

Castle Rock, CO — (SBWIRE) — 02/23/2012

InSer, whose newest IVF fertility clinic is located in Medellín Colombia, is an expert and qualified fertility center that specializes in helping couples achieve their dreams of parenthood. InSer has recently developed a working relationship with PlacidWay, a medical provider that seeks to offer the best in fertility clinics for international travelers.

InSer also has facilities in Pereira and Monteria and most recently, Bogotá. InSer was a sponsor of the 3rd international Symposium of Endometriosis and Fertility in 2010. In 2011, InSer opened their fourth IVF center in Bogotá. “Services offered at our world-renowned facilities include preconception counseling, preimplantation genetic diagnosis, umbilical cord blood stem cell banks,” states Dr. Natalia Posada Villa of the Medellin IVF facility. “We also offer a variety of assisted reproduction treatments including ICSI (intra-cytoplasmic sperm injection), ovulation induction, and artificial insemination”.

“Staff at all InSer IVF facilities are gynecological human reproduction specialists”, “says Pramod Goel, CEO and founder of PlacidWay. “In addition to such specialties, urologists, andrologists, embryologists and biologists are on staff at these facilities, offering international patients the best in education, experience, credentialing and training”.

“InSer is accredited by the Latin American Network of Assisted Reproduction and also offer specialization in human reproduction in well-known educational centers in Europe and the United States,” offers Dr. German David Ospina of the Bogotá facility. Performing more than 400 procedures a year, staff at InSer knows their business. They’ve helped hundreds of women achieve their dreams of motherhood.

“We’re very pleased to begin a new relationship with InSer in Colombia,” concludes Goel. “As an international medical provider and facilitator, were dedicated to offering women around the world options and opportunities that they would not otherwise receive in their homelands.”

About PlacidWay
PlacidWay as a leader in the medical tourism industry, dedicated to offering accurate, up-to-date information and resources regarding medical travel, international medical providers, treatments, procedures and destinations for American and international travelers.

InSer – IVF and Fertility Center – founded in 1995 as a center devoted exclusively to our mission – is an interdisciplinary group of professionals specialized in the area of Human Reproduction in renowned educational centers in Europe and the United States. In 1999 our center earned top research award at the Latin American Federation of Fertility Clinic and Sterility Societies Meeting in Panama

source: http://www.sbwire.com / Placidway / February 23rd, 2012